Article
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
17 Jul 2019
Abstract excerpt
Epstein-Barr virus (EBV) is a ubiquitous human virus which infects almost all humans during their lifetime and following the acute phase, persists for the remainder of the life of the individual. EBV infects B lymphocytes leading to their immortalisation, with persistence of the EBV genome as an episome. In the latent phase, EBV is prevented from reactivating through efficient cytotoxic cellular immunity. EBV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
